Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder

Open access
Young, Allan H, Gallagher, Peter, Watson, Stuart, Del-Estal, Dolores, Owen, Bruce M, Nicol Ferrier, I · 2004 · Neuropsychopharmacology

Abstract

High cortisol levels are found in severe mood disorders, particularly bipolar disorder. Hypercortisolaemia may cause or exacerbate both neurocognitive impairment and depressive symptoms. We hypothesized that antiglucocorticoid treatments, particularly corticosteroid receptor antagonists, would improve neurocognitive functioning and attenuate depressive symptoms in this disorder. To test this hypothesis, 20 bipolar patients were treated with 600 mg/day of the corticosteroid receptor antagonist mifepristone (RU-486) or placebo for 1 week in a double-blind crossover design. Over the total 6 weeks of the study, neurocognitive and neuroendocrine function were evaluated at baseline, days 21 and 42. Mood symptoms were evaluated weekly. Nineteen subjects completed the protocol; there were no drop-outs due to adverse events. Following treatment with mifepristone, selective improvement in neurocognitive functioning was observed. Spatial working memory performance was significantly improved compared to placebo (19.8% improvement over placebo). Measures of verbal fluency and spatial recognition memory were also improved after mifepristone. Beneficial effects on mood were found; Hamilton Depression Rating Scale scores were significantly reduced compared to baseline (mean reduction of 5.1 points) as were Montgomery-Asberg Depression Rating Scale scores (mean reduction of 6.05 points). No significant change occurred after placebo. These data require replication but provide preliminary evidence that glucocorticoid receptor antagonists may have useful cognitive-enhancing and possibly antidepressant properties in bipolar disorder.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300471

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 5

  1. Cegalis J, Bowlin J (1991). Vigil: Software for the Assessment of Attention. Forthought: Nashua, NH.
  2. First MB, Spitzer RL, Williams JBW, Gibbon M (1995). Structured Clinical Interview for DSM-IV (SCID-I), Research Version. Biometrics Research Department, New York State Psychiatric Institute: New York.
  3. Høyberg ØJ, Wik G, Mehtonen OP, Peeters BWMM, Sennef C (2002). ORG 34517, a selective glucocorticoid receptor antagonist with potent antidepressant activity: first clinical results. Int J Neuropsychopharmacol 5: S148.
  4. Lopez JF, Little KY, Lopez-Figueroa AL, Lopez-Figueroa MO, Watson SJ (2003). Glucocorticoid and mineralocorticoid receptor mRNA levels in the hippocampus and prefrontal cortex of subjects with mood disorders and schizophrenia. Biol Psychiatry 53: 489.
  5. Thompson JM, Gray JM, Hughes J, Watson S, Ferrier I, Young AH (2000). A component process analysis of working memory dysfunction in bipolar affective disorder. J Psychopharmacol (Oxf) 14: A24.

Cited by

See all 318

Metadata

Authors
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I.
Affiliations
Newcastle University (GB)
Corresponding author
Young, Allan H
Venue
Neuropsychopharmacology
Published
2004-05-05
Volume
29
Issue
8
Pages
1538-1545
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2041573038
Cited by
318
References
38
Citations by year
2026: 2 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 2 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 14 · 2017: 8 · 2016: 16 · 2015: 13 · 2014: 18 · 2013: 12 · 2012: 14
FWCI
15.34
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Stanley Medical Research Institute
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
mifepristone, RU486, bipolar disorder, glucocorticoid receptor antagonist, hypercortisolism, neurocognitive function, spatial working memory, verbal fluency, spatial recognition memory, depressive symptoms, antidepressant effects, cognitive enhancement
MeSH terms
Adult, Affect, Attention, Bipolar Disorder, Cognition, Double-Blind Method, Female, Hormone Antagonists, Humans, Hydrocortisone, Learning, Male, Memory, Short-Term, Middle Aged, Psychiatric Status Rating Scales, Psychomotor Performance, Receptors, Glucocorticoid, Space Perception, Verbal Learning, Mifepristone, Treatment Outcome, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder. https://app.cochat.ai/papers/10.1038/sj.npp.1300471
The paper
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004). Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1300471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.